Sponsors (3)
The bill increases access to and potential clinical/economic benefits from shorter-duration remote monitoring for Medicare beneficiaries, but it raises fiscal costs, administrative burdens, and risks of overuse or misaligned incentives unless accompanied by robust oversight and clear, lasting payment policies.
Medicare beneficiaries gain easier access to payable remote physiologic/therapeutic monitoring because services become billable with only 2 days of data within 30 days, expanding telehealth options.
Patients (including those with chronic conditions and veterans) can receive earlier, targeted interventions through shorter monitoring windows, which can prevent deterioration and has been associated with substantially fewer admissions and bed days in veteran programs.
Earlier detection and monitoring can reduce hospitalizations and shorten stays, producing potential cost savings for patients and health systems while preserving differential reimbursement by acuity to target resources to higher-need patients.
Taxpayers and the Medicare program could face higher spending because expanding billable monitoring episodes (to a 2-day minimum) will likely increase utilization and program costs.
Medicare beneficiaries and taxpayers risk low-value or unnecessary billing and overuse of brief monitoring episodes if shorter-duration payability is not paired with strong clinical guardrails and oversight.
Healthcare workers and hospitals will face increased administrative burden, workflow and documentation changes, billing-system updates, and additional training to implement and supervise shorter-duration monitoring rules.
Based on analysis of 3 sections of legislative text.
Allows Medicare payment for remote monitoring when at least 2 days of patient-generated data occur in a 30-day period for two years and requires an HHS report on payment models and effects.
Introduced April 28, 2025 by Troy Balderson · Last progress April 28, 2025
Requires Medicare to pay for remote monitoring services when at least 2 days of patient-generated data are collected in a 30-day period for a two-year period beginning at enactment, regardless of COVID–19 diagnosis. Directs HHS to report within one year on prior experience with the 2-day/30-day standard, recommend payment models that account for acuity and cost (including options for differential payments around the current 16-day standard), analyze place-of-service and supervision issues for non-clinical staff, and estimate savings from earlier interventions and fewer hospital days.